Insulet's (PODD) Omnipod Discover platform is now available across US, the company said Monday.
The platform provides personalized diabetes insights, including glucose and insulin delivery reports, for users of Omnipod 5, an automated insulin pump, the company said.
The platform is currently used by more than 15,000 Omnipod 5 users and over 1,800 healthcare professionals as part of its limited market release program in the US, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.